CHIR-98014

Item number	Size	Delivery time	Price
TGM-T2608-5mg	5 mg	7 - 10 business days*	67.00€
TGM-T2608-1mL	1 ml	7 - 10 business days*	72.00€
TGM-T2608-10mg	10 mg	7 - 10 business days*	108.00€
TGM-T2608-25mg	25 mg	7 - 10 business days*	228.00€
TGM-T2608-50mg	50 mg	7 - 10 business days*	371.00€
TGM-T2608-100mg	100 mg	7 - 10 business days*	596.00€
TGM-T2608-500mg	500 mg	7 - 10 business days*	1,259.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CHIR-98014 (CT98014) is a selective GSK3 inhibitor, potentiate insulin activation of... more

Close menu

Product information "CHIR-98014"

Description: CHIR-98014 (CT98014) is a selective GSK3 inhibitor, potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Target: Src, GSK-3, FGFR, S6 Kinase. Smiles: ClC1=C(C=2C(=CN=C(NCCNC=3N=C(N)C(N(=O)=O)=CC3)N2)N4C=CN=C4)C=CC(Cl)=C1. References: Ring DB,et al. Diabetes. 2003, 52(3), 588-595.

Keywords:	CHIR98014, CHIR 98014, CT98014
Supplier:	TargetMol
Supplier-Nr:	T2608

Properties

Application:	GSK3alpha / GSK3beta inhibitor
MW:	486.31 D
Formula:	C20H17Cl2N9O2

Database Information

CAS :	252935-94-7\| Matching products
KEGG ID :	K08822 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CHIR-98014"

Write a review